InvestorsHub Logo
Followers 34
Posts 6562
Boards Moderated 0
Alias Born 09/04/2019

Re: lk52q post# 2535

Friday, 03/11/2022 7:28:48 AM

Friday, March 11, 2022 7:28:48 AM

Post# of 3504
$STAB is making headway as it develops novel immunotherapies targeting emerging viruses, cancers, and autoimmune diseases.

Developing a therapy or drug treatment is a lengthy process that requires approval from federal authorities before it is profitable. In the meantime the company must devote its funding to research and development. But once approved, the payoff can be significant! $STAB